These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 12128092)
1. Transmissible spongiform encephalopathies: the story of a pathogenic protein. Van Everbroeck B; Pals P; Martin JJ; Cras P Peptides; 2002 Jul; 23(7):1351-9. PubMed ID: 12128092 [TBL] [Abstract][Full Text] [Related]
2. The early history of the transmissible spongiform encephalopathies exemplified by scrapie. Schneider K; Fangerau H; Michaelsen B; Raab WH Brain Res Bull; 2008 Dec; 77(6):343-55. PubMed ID: 18951958 [TBL] [Abstract][Full Text] [Related]
3. [Brief history of transmissible spongiform encephalopathies]. Brown P; Bradley R; Cathala F Rev Prat; 1999 May; 49(9):928-33. PubMed ID: 11865456 [TBL] [Abstract][Full Text] [Related]
4. A brief history of prions. Zabel MD; Reid C Pathog Dis; 2015 Dec; 73(9):ftv087. PubMed ID: 26449713 [TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of spongiform encephalopathies: an update. Aguzzi A Int Arch Allergy Immunol; 1996 Jun; 110(2):99-106. PubMed ID: 8646000 [TBL] [Abstract][Full Text] [Related]
9. Metal microcrystal pollutants: the heat resistant, transmissible nucleating agents that initiate the pathogenesis of TSEs? Purdey M Med Hypotheses; 2005; 65(3):448-77. PubMed ID: 15908137 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human prion protein fragment 90-231, a useful model to study prion neurotoxicity. Corsaro A; Thellung S; Villa V; Nizzari M; Aceto A; Florio T OMICS; 2012; 16(1-2):50-9. PubMed ID: 22321015 [TBL] [Abstract][Full Text] [Related]
11. Historical overview of prion diseases: a view from afar. Liberski PP Folia Neuropathol; 2012; 50(1):1-12. PubMed ID: 22505359 [TBL] [Abstract][Full Text] [Related]
12. Notes on the history of the prion diseases. Part I. Poser CM Clin Neurol Neurosurg; 2002 Jan; 104(1):1-9. PubMed ID: 11792469 [TBL] [Abstract][Full Text] [Related]
13. Molecular aspects of disease pathogenesis in the transmissible spongiform encephalopathies. Priola SA; Vorberg I Mol Biotechnol; 2006 May; 33(1):71-88. PubMed ID: 16691009 [TBL] [Abstract][Full Text] [Related]
14. Theoretical analysis of the implication of PrP in neuronal death during transmissible subacute spongiform encephalopathies: hypothesis of a PrP oligomeric channel. Chapron Y; Peyrin JM; Crouzy S; Jaegly A; Dormont D J Theor Biol; 2000 May; 204(1):103-11. PubMed ID: 10772851 [TBL] [Abstract][Full Text] [Related]
15. 1755 and all that: a historical primer of transmissible spongiform encephalopathy. Brown P; Bradley R BMJ; 1998 Dec 19-26; 317(7174):1688-92. PubMed ID: 9857129 [No Abstract] [Full Text] [Related]
17. [Prions--a challenge of Hygieia]. Hörnlimann B Schweiz Arch Tierheilkd; 2005 Jan; 147(1):25-7. PubMed ID: 15693684 [TBL] [Abstract][Full Text] [Related]
18. Fate of prions in soil: a review. Smith CB; Booth CJ; Pedersen JA J Environ Qual; 2011; 40(2):449-61. PubMed ID: 21520752 [TBL] [Abstract][Full Text] [Related]
19. Is loss of function of the prion protein the cause of prion disorders? Hetz C; Maundrell K; Soto C Trends Mol Med; 2003 Jun; 9(6):237-43. PubMed ID: 12829011 [TBL] [Abstract][Full Text] [Related]
20. The use of monoclonal antibodies in human prion disease. Bodemer W Naturwissenschaften; 1999 May; 86(5):212-20. PubMed ID: 10360268 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]